DionyMed Brands Inc. Stock

Equities

DYME

CA25455C1005

Pharmaceuticals

Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for DionyMed Brands Inc. -70.00% -.--%
Sales * - Sales 1 * - Capitalization 50.18M 68.97M
Net income * - Net income 1 * - EV / Sales * -
Net cash position * - 0 Net cash position 1 * - 0 EV / Sales 1 * -
P/E ratio *
-
P/E ratio 1 *
-
Employees -
Yield *
-
Yield 1 *
-
Free-Float 70.35%
More Fundamentals * Assessed data
Dynamic Chart
DionyMed Brands Inc. cancelled the acquisition of Pioneer Valley Extracts, LLC. CI
DionyMed Brands Inc. Announces Board Changes CI
DionyMed Brands Inc. Receives Notice of Default and Demand for Payment and Notice of Intention to Enforce Security CI
DionyMed Brands Inc. Announces Executive Changes CI
DionyMed Announces Executive Changes CI
DionyMed Brands, Inc. Wins Three Provisional Licenses in Los Angeles and San Francisco CI
Dionymed Brands Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
DionyMed Brands Inc. announced that it has received CAD 2.62872 million in funding from Gotham Green Partners, LLC CI
DionyMed Brands Inc. Signs Exclusive Distribution Agreement with Woah Candy Co CI
DionyMed Brands Inc. completed the acquisition of select MMAC assets from MM Esperanza 2 LLC. CI
Innovative Industrial Properties, Inc. completed the acquisition of The Los Angeles Cannabis Campus from DionyMed Brands Inc.. CI
Innovative Industrial Properties, Inc. entered into a definitive agreement with DionyMed Brands Inc. to acquire The Los Angeles Cannabis Campus for $13 million in a sale and leaseback transaction. CI
DionyMed Brands Inc. Signs Exclusive Distribution Agreement with Fruit Slabs CI
DionyMed Brands Inc. announced that it expects to receive CAD 32 million in funding from Alumina Partners Ltd. CI
DionyMed Brands Inc. Reports Revenue Results for the First Quarter Ended March 31, 2019; Provides Revenue Guidance for the Second Quarter Ending June 30, 2019 CI
More news